John S. Macdonald

John S. Macdonald's AcademicInfluence.com Rankings

John S. Macdonald

Philosophy

#7183

World Rank

#10356

Historical Rank

Logic

#4252

World Rank

#5522

Historical Rank

philosophy Degrees

Download Badge

Philosophy

John S. Macdonald's Degrees

Doctorate Medicine Harvard University

Why Is John S. Macdonald Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John S. Macdonald's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction (2001) (2105)
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. (1990) (1793)
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. (1999) (1710)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. (2006) (1441)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. (2002) (1301)
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. (1994) (1106)
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. (2003) (1039)
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. (2001) (943)
A Southwest Oncology Group study (1993) (869)
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. (1996) (760)
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. (2012) (739)
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. (2008) (729)
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. (1997) (552)
Impact of number of nodes retrieved on outcome in patients with rectal cancer. (2001) (546)
Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. (2005) (488)
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. (1993) (434)
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. (2004) (421)
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. (2002) (403)
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. (1998) (365)
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. (2005) (363)
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. (1995) (353)
Impact of diabetes mellitus on outcomes in patients with colon cancer. (2003) (353)
5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. (1980) (332)
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. (2002) (306)
Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma (2003) (304)
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. (2005) (296)
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. (2004) (262)
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. (1997) (257)
Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial (2011) (256)
Accuracy of Determining Nodal Negativity in Colorectal Cancer on the Basis of the Number of Nodes Retrieved on Resection (2003) (249)
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. (2012) (218)
Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. (1981) (218)
A multicenter, Phase II trial of weekly irinotecan (CPT‐11) in patients with previously treated colorectal carcinoma (1999) (195)
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment (2002) (189)
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. (2006) (156)
Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G.E. junction. Results of intergroup study INT-0116 (SWOG 9008) (2001) (155)
Surveillance for Second Primary Colorectal Cancer after Adjuvant Chemotherapy: An Analysis of Intergroup 0089 (2002) (151)
Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. (1980) (147)
Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. (1996) (145)
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. (2002) (143)
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. (2002) (139)
A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study (2005) (138)
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. (2004) (136)
5‐Fluorouracil, adriamycin, and mitomycin‐C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas (1980) (124)
Differences in toxicity between men and women treated with 5‐fluorouracil therapy for colorectal carcinoma (2005) (122)
Tetracycline and quinacrine in the control of malignant pleural effusions. A randomized trial (1978) (119)
Association of Hospital Procedure Volume and Outcomes in Patients with Colon Cancer at High Risk for Recurrence (2003) (117)
5‐fluorouracil, adriamycin, and mitomycin‐c (fam) combination chemotherapy in the treatment of advanced gastric cancer (1979) (115)
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. (2005) (113)
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. (2006) (109)
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy. (1993) (107)
RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. (2006) (107)
PROGNOSTIC FACTORS IN ADVANCED NON-SEMINOMATOUS GERM-CELL TESTICULAR TUMOURS: RESULTS OF A MULTICENTRE STUDY Report from the Medical Research Council Working Party on Testicular Tumours (1985) (106)
Impact of Hospital Volume on Recurrence and Survival After Surgery for Gastric Cancer (2007) (101)
Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study. (1987) (99)
Phase II trial of streptozotocin, mitomycin‐C and 5‐fluorouracil (SMF) in the treatment of advanced pancreatic cancer (1978) (99)
Gastric cancer--new therapeutic options. (2006) (97)
Cutaneous seeding of pancreatic cancer by skinny-needle aspiration biopsy. (1980) (93)
Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A southwest oncology group study (1995) (92)
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid (1994) (88)
Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. (1980) (78)
5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. (1987) (78)
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters. (1976) (78)
The Collaborative UK ECMO Trial: Follow-up to 1 Year of Age (1998) (75)
Computed tomography applied to radiotherapy treatment planning: techniques and results. (1979) (74)
Chemoradiation of resected gastric cancer: A 10-year follow-up of the phase III trial INT0116 (SWOG 9008). (2009) (73)
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. (2011) (73)
Endocrine tumors. (1987) (70)
Adjuvant therapy of colon cancer (1999) (69)
Adjuvant therapy for colon cancer (1997) (68)
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. (2013) (67)
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer. (1978) (67)
Alterations in exon 4 of the p53 gene in gastric carcinoma. (2000) (67)
The role of computed tomography in the staging of bladder cancer. (1979) (64)
Carcinoembryonic antigen screening: pros and cons. (1999) (63)
Nutritional complications of cancer and its treatment. (1975) (57)
Clinical overview: adjuvant therapy of gastrointestinal cancer (2004) (57)
Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. (1998) (51)
Role of post‐operative chemoradiation in resected gastric cancer (2005) (47)
Cutaneous T‐cell lymphoma (1976) (47)
Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-L-aspartate on cell growth and ribonucleic acid synthesis in human mammary carcinoma. (1981) (47)
Treatment of localized gastric cancer. (2004) (46)
Association of breast cancer with meningioma. Report of two cases and review of the literature (1978) (46)
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy (1988) (42)
A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial. (2005) (42)
The role of computed tomography in the management of testicular teratoma. (1979) (42)
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A southwest oncology group study (1993) (42)
Hepatic chemoembolization combined with systemic infusion of 5‐fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma (1999) (42)
Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study. (1992) (42)
p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. (1999) (39)
Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. (2007) (38)
Effect of sulfhydryl-containing compounds on the antitumor effects of adriamycin. (1980) (37)
A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: a Southwest Oncology Group study. (1991) (37)
Phase I clinical trial of spirogermanium. (1980) (37)
Adjuvant therapy for colon cancer. (2001) (36)
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study. (1994) (35)
Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study (2004) (35)
delta 9-tetrahydrocannabinol in clinical oncology. (1981) (34)
5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU. (1976) (34)
Gastric cancer: Nagoya is not New York. (2011) (33)
5‐fluorouracil, adriamycin, and mitomycin‐C (FAM) chemotherapy for adenocarcinoma of the lung (1979) (32)
Manual of oncologic therapeutics (1995) (31)
A review of the role of lymphography in the management of testicular tumours. (1975) (31)
The role of abdominal computed tomography in the management of testicular tumours. (1980) (30)
Synergy between cetuximab and chemotherapy in tumors of the gastrointestinal tract. (2008) (30)
Chemotherapy of advanced gastric cancer: present status, future prospects. (1988) (29)
The relation of p53 gene mutations to gastric cancer subsite and phenotype (1999) (29)
Δ9-Tetrahydrocannabinol in Clinical Oncology (1981) (29)
Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate. (2007) (28)
Methyl mercury-induced encephalopathy in mice. (1977) (28)
Autoimmune neutropenia following peripheral blood stem cell transplantation (1992) (28)
A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study. (1990) (27)
Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060 (1996) (27)
Clinical Trials with Antiemetic Agents in Cancer Patients Receiving Chemotherapy (1981) (26)
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial. (2002) (26)
Adjuvant treatment of gastric cancer (1995) (25)
Spontaneous streptococcus pneumonia peritonitis in a patient with metastatic gastric cancer. A case report and etiologic consideration (1977) (25)
Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study. (1995) (25)
Gastric cancer: Chemotherapy of advanced disease (1992) (25)
Gastrointestinal involvement in the Sézary syndrome. (1977) (24)
LYMPHANGIOGRAPHY IN TUMOURS OF THE KIDNEY, BLADDER AND TESTICLE. (1965) (24)
Current diagnosis and management of pancreatic carcinoma. (1976) (24)
Oral fluoropyrimidines: a closer look at their toxicities. (1999) (24)
Chemotherapy of large intestinal carcinoma. Current results and future prospects (1975) (23)
Observations on the growth of tumours in lymph nodes changing from normal to abnormal while remaining opacified after lymphography. (1968) (23)
Tumorigenicity of 7,12-dimethylbenz[a]anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse. (1981) (23)
Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma. (1982) (22)
Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009 (1999) (22)
The accuracy of lymphography in Hodgkin's disease. (1974) (22)
Phase II trial to topotecan in hepatocellular carcinoma: A Southwest Oncology Group study (2004) (22)
The value of lymphography in the management of carcinoma of the cervix. (1986) (21)
A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer (1991) (21)
Vive la difference: sex and fluorouracil toxicity. (2002) (21)
Phase II study of 5‐fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study (1995) (21)
Continuous low-dose infusion of fluorouracil: is the benefit worth the cost? (1989) (20)
Phase-II trial of tamoxifen in advanced breast cancer (2004) (20)
Osteoblastic bone metastasis in Zollinger-Ellison syndrome. (1976) (19)
Role of lymphography in carcinoma of the prostate. (1975) (19)
39 : RTOG 9704 - Radiotherapy Quality Assurance (QA) Review and Survival (2006) (19)
Lymphography in carcinoma of the uterus. (1972) (18)
Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study (2006) (18)
Does Leucovorin Alter the Intratumoral Pharmacokinetics of 5-Fluorouracil (5-FU)? A Southwest Oncology Group Study (2002) (18)
Chemotherapy of gastric cancer. (1989) (18)
The value of lymphography in the management of bladder cancer. (1976) (17)
Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man. (1980) (17)
Biology, diagnosis, and chemotherapeutic management of pancreatic malignancy. (1977) (17)
Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study. (2002) (17)
A phase II multi‐institutional trial of low‐dose N‐(phosphonacetyl)‐L‐aspartate and high‐dose 5‐fluorouracil as a short‐term infusion in the treatment of adenocarcinoma of the pancreas. A southwest oncology group study (1991) (17)
Some considerations concerning the dose and schedule of 5FU and leucovorin: toxicities of two dose schedules from the intergroup colon adjuvant trial (INT-0089). (1993) (16)
Computed Tomography in Testicular Disease: A Review (1981) (16)
FIBROMUSCULAR HYPERPLASIA OF THE RENAL ARTERIES. (1963) (15)
Mitomycin therapy in gastric cancer. (1993) (15)
Phase-II trial of tamoxifen in advanced breat cancer. (1979) (15)
Fast neutron irradiation for locally advanced pancreatic cancer. (1981) (15)
A Phase II Trial of Etoposide, Leucovorin, 5-FU, and Interferon Alpha 2b (ELFI) + G-CSF for Patients with Pancreatic Adenocarcinoma: a Southwest Oncology Group Study (SWOG 9413) (2000) (14)
A Phase II Trial of Topotecan in Esophageal Carcinoma: A Southwest Oncology Group Study (SWOG 9339) (2000) (14)
Phase II trial of oral β-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157) (2004) (14)
Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer. (1978) (13)
A phase II trial of ftorafur. Adriamycin and mitomycin‐C (FAM II) in advanced gastric adenocarcinoma (1979) (13)
The Cancer Therapy Evaluation Program of the National Cancer Institute. (1981) (13)
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial. (2012) (13)
Etoposide in gastric cancer. (1992) (13)
5‐fluorouracil and interferon‐alpha‐2a in advanced colorectal cancer. Results of two treatment schedules (1993) (13)
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241) (2004) (12)
High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers. (1992) (12)
Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study (2004) (12)
Treatment of non-small cell lung cancer with coumarin and cimetidine. (1987) (12)
Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach (2016) (11)
The value of lymphography to the radiotherapist. (1969) (11)
Chapter 11 – SUBACUTE AND CHRONIC TOXICITIES ASSOCIATED WITH NITROSOUREA THERAPY (1981) (11)
COMPUTERISED AXIAL TOMOGRAPHY FOR DIAGNOSIS OF PANCREATIC CANCER (1976) (11)
Lymphography in the management of urinary tract tumours. (1968) (11)
Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study. (1990) (10)
The potential for clinical application of in vitro assays predicting 5-FU sensitivity in man. (1981) (10)
In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea. (1980) (10)
A randomized trial of two schedules of trimetrexate versus 5‐fluorouracil in advanced colorectal cancer: a Southwest Oncology Group Study (1995) (10)
Selective transseptal angiocardiography of the left side of the heart. (1962) (10)
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture. (2003) (10)
Bone changes in adult acute leukaemia. (1968) (9)
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm (2004) (9)
Phase II Trial of Merbarone in Pancreatic Carcinoma: A Southwest Oncology Group Study (1993) (9)
Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential. (1982) (9)
"High-dose" thymidine in clinical oncology. (1981) (9)
Advances in the therapy of gastric cancer (2002) (9)
Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer (2002) (8)
Post-resection CA 19–9 predicts overall survival (OS) in patients treated with adjuvant chemoradiation: A secondary endpoint of RTOG 9704 (2007) (8)
Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: A Southwest Oncology Group study (2006) (8)
Indicine-N-oxide: a new antitumor agent. (1981) (8)
Adjuvant therapy for gastric cancer. (2003) (8)
Adjuvant therapy of gastrointestinal cancer (1987) (7)
Number of Lymph Nodes Analyzed : A Secondary Survey of Intergroup Tria l INT-0089 (2003) (7)
The detection and localisation of abdominal lymph node metastases from testicular teratomas. (1977) (7)
Phase II trial of recombinant DNA gamma-interferon in advanced colorectal cancer: a Southwest Oncology Group study. (1991) (7)
Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study. (1987) (7)
CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung. (1981) (7)
Synthesis and pharmacological study of a polymer which selectively binds mercury. (1977) (7)
Phase II Evaluation of Low‐Dose Continuous 5‐Fluorouracil and Weekly Cisplatin in Advanced Adenocarcinoma of the Stomach: A Southwest Oncology Group Study (1995) (7)
Improved therapeutic ratio with protracted venous infusion (PVI) 5-fluorouracil (5FU) during postoperative external beam radiotherapy for high-risk rectal cancer (1993) (6)
Lymphatic Surgery (1972) (6)
Palliative chemotherapy and hormonal therapy. (1985) (6)
Metastases to bone from malignant melanoma. (1972) (6)
Correlation of RTOG 9704 (adjuvant therapy (rx) of pancreatic adenocarcinoma (pan ca)) radiation therapy quality assurance scores (RTQASc) with survival (S) (2007) (6)
Recent results of clinical therapeutic trials for gastrointestinal malignancies conducted in the United States. (1981) (6)
Mitomycin C: Experience in the United States, with emphasis on gastric cancer (2004) (6)
Assessment of HER 2 gene ampli fi cation in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116 / SWOG 9008 clinical trial (2013) (6)
Ratio of metastatic to examined lymph nodes is a powerful predictor of overall survival in rectal cancer: An analysis of Intergroup 0114 (2007) (6)
2'-deoxycoformycin. A new anticancer agent. (1981) (5)
ICRF-187 in clinical oncology. (1981) (5)
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study. (2005) (5)
S9511: A Southwest Oncology Group Phase II Study of Trimetrexate, 5-Fluorouracil, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach (2009) (5)
Chemotherapy in the management of gastric cancer. (2003) (5)
Chemotherapy of adenocarcinoma of the pancreas. (1996) (5)
Therapy of Advanced Gastric Carcinoma: The Georgetown‐Lombardi Cancer Center Experience (1989) (5)
Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin (1979) (5)
RADIOTHERAPY TREATMENT PLANNING: INITIAL CLINICAL EXPERIENCE USING A WHOLE BODY CI SCANNER DIRECTLY LINKED TO A TREATMENT PLANNING COMPUTER (1978) (4)
Hexamethylmelamine in advanced head and neck cancer A phase II study (1984) (4)
A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study. (1993) (4)
CANCER CHEMOTHERAPY AND THE LIVER (1998) (4)
42 : A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre and Post Chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcinoma (2006) (4)
Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study. (1994) (4)
Diagnosis and treatment of colorectal cancer. (1978) (4)
Phase II trial of trimetrexate in advanced esophageal cancer: A southwest oncology group study (1995) (4)
Adjuvant chemotherapy in colon and gastric cancer. (1982) (4)
Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors. (1979) (4)
Update on Adjuvant Therapy of Colon Cancer (1997) (4)
High-dose cisplatin in disseminated melanoma: a comparison of two schedules (2004) (4)
ELUSIVE TUMOURS IN THE CERVICAL SPINAL CANAL. (1964) (4)
Intergroup 0116 (SWOG 9008)- phase III trial of postoperative adjuvant radiochemotherapy for high risk gastric and gastroesophageal junction adenocarcinoma: Evaluation of efficacy and radiotherapy treatment planning (2000) (4)
The CT appearances of hepatic oil embolism following lymphography. (1984) (3)
Preoperative adjuvant chemotherapy in relatively advanced head and neck cancer (1984) (3)
A phase II trial of continuous infusion vinblastine in patients with gastric carcinoma. A Southwest Oncology Group study. (1990) (3)
Post-resectional CA 19-9 Values >90 are Associated With Significantly Worse Survival in Patients With Pancreatic Carcinoma Treated With Adjuvant Therapy on RTOG 9704 - Implications for Current and Future Trials (2007) (3)
Adopting postoperative chemoradiotherapy in resected gastric cancer. (2009) (3)
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study (2004) (3)
SAMIT: Preliminary safety data from a 2x2 factorial randomized phase III trial to investigate weekly paclitaxel (PTX) followed by oral fluoropyrimidines (FPs) versus FPs alone as adjuvant chemotherapy in patients (pts) with gastric cancer. (2011) (3)
The effect of sequential addition of the nitrosourea, chlorozotocin, to the FAM combination in advanced gastric cancer (1983) (3)
m-AMSA: an exciting new drug in the National Cancer Institute Drug Development Program. (1980) (3)
Treatment of advanced colorectal carcinoma with 5-fluorouracil, leucovorin and Roferon-A: a Southwest Oncology Study Group Study. (1994) (3)
Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU. (1982) (3)
Bis-diketopiperazine derivatives in clinical oncology: ICRF-159. (1980) (3)
Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group study. (1991) (3)
Phase II trial of piroxantrone in gastric carcinoma (1994) (2)
Lymphatic diverticulum: a persistent posterior lymph sac demonstrated by lymphography. (1977) (2)
Delivering Effective & Meaningful Survivorship Care (2010) (2)
Amonafide treatment of refractory esophageal cancer (1993) (2)
Hepatoma/merbarone (2004) (2)
Parathyroid neoplasia (1991) (2)
The Impact of Chemotherapy on the Treatment of Gastric Cancer (1983) (2)
Phase II trial of amonafide in advanced pancreas cancer (1993) (2)
Phase II trial of trimetrexate in untreated advanced gastric carcinoma (2004) (2)
Phase II trial of echinomycin in advanced colorectal cancer (1991) (2)
Lymphography in alveolar soft part sarcoma. (1977) (2)
Lymphography in Tumours of the Urogenital Tract (1978) (2)
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study (1993) (2)
Patient Support Services & Patient Satisfaction (2009) (2)
Cancer patients’ use of supportive care services and cancer center services satisfaction (2008) (2)
VM-26 in gastric cancer (1993) (2)
Adjuvant paclitaxel followed by oral fluoropyrimidines for gastric cancer: Safety data of the factorial phase III SAMIT trial. (2012) (2)
Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma (1993) (2)
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin. A Southwest Oncology Group study. (1991) (1)
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study (2004) (1)
The FAM regimen for gastric cancer: a progress report. (1981) (1)
A phase II study of chemotherapy of metastatic colorectal carcinoma with 5-fluorouracil plus cisplatin (1991) (1)
Total Nodes Examined (TNE) and Number of Positive Nodes (NPN) Predict Survival in Patients Undergoing Pancreaticoduodenectomy (PD) Followed by Adjuvant Chemoradiation (CRT) for Pancreatic Cancer—A Secondary Analysis of RTOG 9704 (2008) (1)
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-Fluorouracil in advanced gastric adenocarcinoma (1996) (1)
Changes in the size of pelvic lymph nodes in patients being followed after radiotherapy for Hodgkin's disease. (1980) (1)
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma (2004) (1)
Clinical strategies in the chemotherapy of gastrointestinal cancer. (1980) (1)
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study (2004) (1)
Chemotherapy of colorectal carcinoma. (1976) (1)
New horizons for gastric cancer: commentary (2006) (1)
High incidence of coagulopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers (1992) (1)
Accrual patterns of the Southwest Oncology Group (SWOG) by sex, race/ethnicity, and age: Updated and expanded analyses. (2004) (1)
Chemotherapy of metastatic gastrointestinal cancers: prospects for future adjuvant systemic therapies. (1982) (1)
Gastroesophageal cancer: understanding the disease process and advancing therapy. (2007) (1)
Therapies for Advanced Colorectal Cancer: The Role of Interferon and Leucovorin (1997) (1)
Oxaliplatin: New Opportunities for the Treatment of Gastrointestinal Cancer (2002) (1)
Prediction of clinical response to 5-fluorouracil-containing chemotherapy: preliminary results of in vitro assay in human breast cancer. (1980) (1)
An introduction to current controversies in cancer management: stage I testicular cancer-a case in point. (1982) (1)
The lymphographic pattern in Hodgkin's disease: a correlation with the Rye histological classification. (1976) (1)
VM-26 in colorectal carcinoma: A Southwest Oncology Group study (1990) (1)
Pharmacokinetics of ondansetron in patients receiving cisplatin therapy. (1992) (1)
Adjuvant therapy of colorectal cancer: where do we stand? (1989) (1)
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group study. (1990) (1)
Phase II trial of menogaril in adenocarcinoma of the pancreas (1991) (0)
Conclusions: The addition of bevacizumab to chemoradiation followed by bevacizumab and gemcitabine resulted in similar me- dian and 1 year survival and acute toxicity rates to similar studies conducted by the RTOG in the past. (2007) (0)
Zotocin, (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (cholo-2- -ethyl)-1-ribopyranosyl-3-nitrosouruea. (1980) (0)
A phase III randomized double blind chemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer: A year-six update. (2006) (0)
A new in vitro predictive assay for response to 5-fu chemotherapy in murine and human tumors. Abstr. (1978) (0)
From the bench to the bedside: clinical management of unusual tumors (1999) (0)
Gastrointestinal Oncology: Basic and Clinical Aspects (1987) (0)
Postoperative radiation plus chemotherapy increases survival in rectal cancer (1991) (0)
Book reviewsAtlas of Lymphography. By ViamonteM. and RüttimannA., pp. xi+456, 1980 (Georg Thieme, Verlag Stuttgart), DM.198. ISBN 3–13–5478–01–7 (1981) (0)
Unusual Cancers of the Pancreas (2012) (0)
Clinical Radiology in the Lymphomas. By Henry Ngan and Keith W. James. Published by Butterworths. (Radiology in Clinical Diagnosis Series.) (1974) (0)
Treatments of choice in gastric cancer. (1978) (0)
Adjuvant therapy of colon cancer in the elderly (2002) (0)
An international multidisciplinary approach to the management of advanced colorectal cancer (First of two parts) (Reprinted from Eur J Surg Oncol, vol 23, Suppl A, August 1997) (1998) (0)
ReviewsMéthode anatomo-clinique d'Exploration de l'Appareil circulatoire et Techniques opératoire. By EcoiffierJ., pp. 288, 114 illus., 1966 (Masson & Cie., Paris), F.70. (1967) (0)
A phase II trial of piroxantrone in adenocarcinoma of the pancreas (1993) (0)
New modalities needed for esophageal cancer. (1978) (0)
559 Predictive Markers of Gemcitabine Treatment Response in Pancreas Cancer: A Pharmacogenomic Pathway Approach (2012) (0)
Endocrine tumors: molecular biology at the bedside? (1994) (0)
Book reviewsRoentgenology of Lymphomas and Leukemias. By FelsonBenjamin, pp. x+134, 1980 (Grune and Stratton, New York), $24.50. ISBN 0–8089–1333–6 (1981) (0)
Mechanisms and management of malnutrition states in patients with cancer. (1976) (0)
Para-aortic nodes in carcinoma of the cervix (1981) (0)
Adjuvant therapy of colon cancer. (2001) (0)
Diagnosing and treating cancer of the pancreas. (1978) (0)
Lymphography in renal tumours. (1969) (0)
Evaluating associations of diabetes, insulin use, and BMI with efficacy in patients with resected pancreatic cancer: An ancillary analysis of NRG Oncology/RTOG 9704. (2017) (0)
Adjuvant chemoradiation therapy (CRT) for resected gastric cancer (GC): A population-based study. (2016) (0)
Gastric Cancer: Are There New Therapeutic Options? (2007) (0)
Hexamethylmelamine: activity in lymphoma and other tumors. (1991) (0)
Plans for ISGIO's Fourth Annual GI Oncology Conference Under Way (2007) (0)
Abstracts reprinted from Journal of Clinical Oncology (2007) (0)
Adjuvant therapy in colorectal carcinoma. (1991) (0)
Prostate cancer. Lymphography. (1981) (0)
Impact o f D iabetes M ellitus o n O utcomes i n P atients W ith Colon C ancer (2003) (0)
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin. (1982) (0)
Book ReviewLa Radiographie a Contraste Optimal en Technique Haute et Basse Tension. By O. Leguern, J. Remy and Y. M. Allain. Published by Delachaux & Niestle S.A., Paris & Neuchatel. Pp. 129. 67 reproductions of radiographs and numerous graphs. (1967) (0)
Gastric Carcinoma: Classification, Diagnosis, and Therapy, Hotz Jurgen, Meyer Hans-Joachim, Schmoll H.J. (Eds.). Springer-Verlag New York Inc., New York, New York (1989), 194 pp., $39.95. ISBN: 0-387-96955-1 (1990) (0)
Book reviewsLa Lymphographie Normale et Pathologique. By GrelletJ., MarkovitsP., HeitzF. and GasquetC., pp. 119 (Neuchatel and Paris, Delachaux & Niestlé). (1970) (0)
La Lymphographie Normale et Pathologique. J. Grellet, P. Markovits, F. Heitz and C. Gasquet. Published by Delachaux & Niestlè, Neuchatel & Paris. (1970) (0)
A new in vitro assay for response to 5-FU chemotherapy in murine and human tumors (1978) (0)
A phase II study of menogaril (NSC-269148) in colorectal carcinoma (1990) (0)
Book reviewsAnatomie des Lymphatiques DeL'Homme (French text). By RouvièreH., pp. viii + 489, 1981 (Masson, Paris), Price not given. ISBN 2–225–69388–9 (1982) (0)
Book review“Traité de Radiodiagnostic. Tome IV” Appareil Pulmonaire et Mediastin: Volume I. Edited BismuthV., pp. 528, illus., 1977 (Masson, Paris). $171.60, 660FF. (1977) (0)
Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma (1991) (0)
Pancreatic cancer. (1996) (0)
Current Results and Therapeutic Issues (1989) (0)
Toxicity of 5-fluorouracil. (1999) (0)
Seeds, External Beam RT Equally Effective in Early-Stage Disease (1998) (0)
Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study. (1991) (0)
ALL SOUTHWEST ONCOLOGY GROUP MEMBER, CCOP AND AFFILIATE MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, SURGEONS AND PATHOLOGISTS; ECOG AND RTOG (2002) (0)
Endocrine tumors. (1992) (0)
Update on endocrine neoplasia: practical translation research (1997) (0)
Atlas of Lymphography, T. de Roo. Stenfert Kroese, Wien, Heidelberg, Berlin (1975), 190 pages, 387 illustrations. Price Dji. 85 (1975) (0)
GI cancer: the statistics. (1978) (0)
Urological Radiology (1970) (0)
Endocrine tumors: Editorial overview (1990) (0)
Mitomycin C: experience in the United States, with emphasis on gastric cancer. (1978) (0)
Book reviewDiagnosis and staging of cancer. A radiologic approach. SteckelR. J., and KaganA. R., pp. xx + 376, 1976 (Sussex, W. B. Saunders & Co.), £16·50. (1977) (0)
CT IN PELVIC TUMORS (1978) (0)
CT IN TESTICULAR TERATOMAS (1978) (0)
Point/Counterpoint. NCI Clinical Alert policy. Sometimes a great notion. (1990) (0)
Unusual Pancreatic Tumors (2006) (0)
Book reviewsAtlas of Axial Transverse Tomography and Its Clinical Application. By TakahashiShinji, 1969 (Berlin, Heidelberg and New York, Springer-Verlag), DM.144. (1970) (0)
Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity. (1980) (0)
Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study. (1991) (0)
Endocrine tumors. (1996) (0)
Quality Care, Outcome, Cost … A Complex Balance for Hospitals (2007) (0)
Pros and cons of infusional 5-FU as adjuvant therapy for colon cancer. (1990) (0)
The Lymphatics. Diseases, Lymphography and Surgery, J.B. Kinmonth. Edward Arnold, London (1972), 399 pp. well illustrated with some in colour (1973) (0)
PHASE III TRIAL OFADJUVANT CHEMOTHERAPYAND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS (2011) (0)
Commentary (Macdonald)—Adjuvant Therapy for Gastric Carcinoma: Closing out the Century (1999) (0)
Unusual skin reaction to echinomycin. (1987) (0)
Book reviewsSoft Tissue Roentgenography in Diagnosis of Thyroid Cancer. By AkisadaMasayoshi and FujimotoYoshihide, pp. 138 (47 figs., 166 illus.), 1973 (Tokyo, Igaku Shoin Ltd.), ¥3,400. (1974) (0)
Management of Gastric and Pancreatic Cancer (1980) (0)
Advances in imaging techniques in neuroendocrine tumors: miscellaneous papers of interest. (1990) (0)
ReviewsLa Radiographie à Contraste optimal en Technique haute et basse tension. By, LeguernO., RemyJ. and AllainY. M., pp. 129, 67 illus., 1966 (Paris and Neuchatel, Delachaux & Niestle S. A.) (1967) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John S. Macdonald?

John S. Macdonald is affiliated with the following schools: